Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors

MLA

Masahiro Toda, et al. “Quantitative Assessment and Clinical Relevance of VEGFRs-Positive Tumor Cells in Refractory Brain Tumors.” Experimental and Molecular Pathology, vol. 114, June 2020, p. 104408. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26fd6b155a847573f9296557c8b51194&authtype=sso&custid=ns315887.

APA

Masahiro Toda, Kazunari Yoshida, Makoto Murase, Kentaro Ohara, Yumiko Oishi, Mizuto Sato, Kenzo Kosugi, Ryota Tamura, Yukina Morimoto, & Yuki Kuranari. (2020). Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Experimental and Molecular Pathology, 114, 104408.

Chicago

Masahiro Toda, Kazunari Yoshida, Makoto Murase, Kentaro Ohara, Yumiko Oishi, Mizuto Sato, Kenzo Kosugi, Ryota Tamura, Yukina Morimoto, and Yuki Kuranari. 2020. “Quantitative Assessment and Clinical Relevance of VEGFRs-Positive Tumor Cells in Refractory Brain Tumors.” Experimental and Molecular Pathology 114 (June): 104408. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....26fd6b155a847573f9296557c8b51194&authtype=sso&custid=ns315887.